Abstract
α4β7+ Tr17 and CD8+ T cells mediate immune-suppressive or immune-stimulatory effects for immune checkpoint blockade, respectively.
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.